GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+3.83%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$261M
AUM Growth
+$261M
Cap. Flow
-$46.6M
Cap. Flow %
-17.84%
Top 10 Hldgs %
50.42%
Holding
67
New
9
Increased
18
Reduced
11
Closed
21

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$9.42M
2
SRPT icon
Sarepta Therapeutics
SRPT
$9.01M
3
MRUS icon
Merus
MRUS
$8.75M
4
APLS icon
Apellis Pharmaceuticals
APLS
$5.91M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
$5.09M

Top Sells

1
XENE icon
Xenon Pharmaceuticals
XENE
$21.6M
2
IOVA icon
Iovance Biotherapeutics
IOVA
$17.3M
3
ALLK
Allakos
ALLK
$9M
4
GHRS icon
GH Research
GHRS
$7M
5
ALDX icon
Aldeyra Therapeutics
ALDX
$6.15M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
STSA
26
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$4.07M 1.46%
904,225
– –
VTGN icon
27
VistaGen Therapeutics
VTGN
$113M
$3.9M 1.4%
2,000,000
– –
TARS icon
28
Tarsus Pharmaceuticals
TARS
$2.44B
$3.83M 1.37%
170,000
– –
BLU
29
DELISTED
BELLUS Health Inc.
BLU
$3.62M 1.3%
450,000
+50,000
+13% +$403K
CRNX icon
30
Crinetics Pharmaceuticals
CRNX
$3.26B
$3.36M 1.2%
118,344
-31,656
-21% -$899K
PYXS icon
31
Pyxis Oncology
PYXS
$91.2M
$3.24M 1.16%
+295,000
New +$3.24M
NMTR
32
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
$3.18M 1.14%
3,250,000
+500,000
+18% +$489K
KURA icon
33
Kura Oncology
KURA
$732M
$3.15M 1.13%
225,000
-200,000
-47% -$2.8M
XENE icon
34
Xenon Pharmaceuticals
XENE
$2.99B
$3.12M 1.12%
100,000
-690,000
-87% -$21.6M
CTIC
35
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.98M 1.07%
1,200,000
-400,000
-25% -$992K
DSGN icon
36
Design Therapeutics
DSGN
$339M
$2.89M 1.04%
+135,000
New +$2.89M
LRMR icon
37
Larimar Therapeutics
LRMR
$337M
$2.43M 0.87%
225,000
+25,000
+13% +$270K
GHRS icon
38
GH Research
GHRS
$870M
$2.33M 0.84%
100,000
-300,000
-75% -$7M
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.76M 0.63%
+60,000
New +$1.76M
IMUX icon
40
Immunic
IMUX
$79.4M
$1.58M 0.57%
165,000
-100,000
-38% -$957K
RETA
41
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.45M 0.52%
+55,000
New +$1.45M
PRDS
42
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$819K 0.29%
+50,000
New +$819K
CABA icon
43
Cabaletta Bio
CABA
$144M
$512K 0.18%
135,000
+35,000
+35% +$133K
OTIC
44
DELISTED
Otonomy, Inc.
OTIC
– –
-450,000
Closed -$864K
PRVB
45
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-50,000
Closed -$320K
TCRR
46
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-477,323
Closed -$4.06M
TBIO
47
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
– –
-35,000
Closed -$390K
CMRX
48
DELISTED
Chimerix, Inc.
CMRX
– –
-200,000
Closed -$1.24M
PRAX icon
49
Praxis Precision Medicines
PRAX
$980M
– –
-250,000
Closed -$4.62M
MRNA icon
50
Moderna
MRNA
$9.36B
– –
-5,300
Closed -$2.04M
1
2
3